Actualités réglementaires
19 sept. 2026•1 min de lecture
FDA Approves Alembic’s Generic Lithium Carbonate Capsules (ANDA 079159)
The FDA has granted approval for Alembic Pharmaceuticals’ generic lithium carbonate oral capsules in 150 mg, 300 mg, and 600 mg strengths under ANDA 079159.
Actualités réglementaires
30 août 2026•1 min de lecture
FDA Approves Hikma International Pharmaceutics' Lithium Carbonate Tablet (ANDA 078715)
FDA approved Hikma International Pharmaceutics' generic lithium carbonate 300 mg tablet (ANDA 078715) on Dec 28 2010, with a labeling supplement approved in 2012.